You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,951,190


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,951,190 protect, and when does it expire?

Patent 11,951,190 protects PLUVICTO and is included in one NDA.

This patent has sixty-three patent family members in twenty-eight countries.


Drugs Protected by US Patent 11,951,190

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novartis PLUVICTO lutetium lu-177 vipivotide tetraxetan SOLUTION;INTRAVENOUS 215833-001 Mar 23, 2022 RX Yes Yes 11,951,190 ⤷  Subscribe FOR TREATMENT OF ADULT PATIENTS WITH PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-POSITIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) WHO HAVE BEEN TREATED WITH ANDROGEN RECEPTOR (AR) PATHWAY INHIBITION AND TAXANE-BASED CHEMOTHERAPY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,951,190

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 4095130 ⤷  Subscribe CA 2024 00027 Denmark ⤷  Subscribe
European Patent Office 4095130 ⤷  Subscribe LUC00352 Luxembourg ⤷  Subscribe
European Patent Office 4095130 ⤷  Subscribe 301281 Netherlands ⤷  Subscribe
European Patent Office 4095130 ⤷  Subscribe PA2024522 Lithuania ⤷  Subscribe
European Patent Office 4095130 ⤷  Subscribe 2024C/528 Belgium ⤷  Subscribe
European Patent Office 4095130 ⤷  Subscribe 122024000038 Germany ⤷  Subscribe
Australia 2014336638 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.